Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. [electronic resource]
- Diabetic medicine : a journal of the British Diabetic Association Feb 2006
- 141-7 p. digital